Your browser doesn't support javascript.
loading
Combining SNAPs with antibiotics shows enhanced synergistic efficacy against S. aureus and P. aeruginosa biofilms.
Maset, Ramón Garcia; Hapeshi, Alexia; Lapage, John; Harrington, Niamh; Littler, Jenny; Perrier, Sébastien; Harrison, Freya.
Affiliation
  • Maset RG; Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK. r.maset@ucl.ac.uk.
  • Hapeshi A; Department of Chemistry, University of Warwick, Coventry, CV4 7AL, UK.
  • Lapage J; School of Life Sciences, University of Warwick, Coventry, CV4 7AL, UK.
  • Harrington N; Department of Evolution, Ecology and Behaviour, Institute of Infection, Veterinary and Ecological Science, University of Liverpool, Liverpool, L69 7ZV, UK.
  • Littler J; School of Life Sciences, University of Warwick, Coventry, CV4 7AL, UK.
  • Perrier S; Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK. S.Perrier@warwick.ac.uk.
  • Harrison F; Department of Chemistry, University of Warwick, Coventry, CV4 7AL, UK. S.Perrier@warwick.ac.uk.
NPJ Biofilms Microbiomes ; 9(1): 36, 2023 Jun 08.
Article in En | MEDLINE | ID: mdl-37291132
ABSTRACT
Biofilm infections are associated with a high mortality risk for patients. Antibiotics perform poorly against biofilm communities, so high doses and prolonged treatments are often used in clinical settings. We investigated the pairwise interactions of two synthetic nano-engineered antimicrobial polymers (SNAPs). The g-D50 copolymer was synergistic with penicillin and silver sulfadiazine against planktonic Staphylococcus aureus USA300 in synthetic wound fluid. Furthermore, the combination of g-D50 and silver sulfadiazine showed a potent synergistic antibiofilm activity against S. aureus USA300 using in vitro and ex vivo wound biofilm models. The a-T50 copolymer was synergistic with colistin against planktonic Pseudomonas aeruginosa in synthetic cystic fibrosis medium, and this pair showed a potent synergistic antibiofilm activity against P. aeruginosa in an ex vivo cystic fibrosis lung model. SNAPs thus have the potential for increased antibiofilm performance in combination with certain antibiotics to shorten prolonged treatments and reduce dosages against biofilm infection.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Cystic Fibrosis / Methicillin-Resistant Staphylococcus aureus Limits: Humans Language: En Journal: NPJ Biofilms Microbiomes Year: 2023 Type: Article Affiliation country: United kingdom

Full text: 1 Database: MEDLINE Main subject: Cystic Fibrosis / Methicillin-Resistant Staphylococcus aureus Limits: Humans Language: En Journal: NPJ Biofilms Microbiomes Year: 2023 Type: Article Affiliation country: United kingdom